• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锝-99m甲氧基异丁基异腈闪烁扫描术检测转移性甲状腺岛状癌

Tc-99m MIBI scintigraphic detection of metastatic insular thyroid carcinoma.

作者信息

Zak I T, Seabold J E, Gurll N J

机构信息

Department of Radiology, University of Iowa College of Medicine, Iowa City 52242.

出版信息

Clin Nucl Med. 1995 Jan;20(1):31-6. doi: 10.1097/00003072-199501000-00008.

DOI:10.1097/00003072-199501000-00008
PMID:7895433
Abstract

Thallium-201 and, recently, Tc-99m MIBI have been used in conjunction with I-131 scintigraphy for follow-up of patients with well-differentiated thyroid cancer. Insular carcinoma of the thyroid is a fairly aggressive thyroid neoplasm that is believed to arise from follicular cells and usually concentrates I-131. The authors report a patient with recurrent insular thyroid carcinoma in whom bilateral adrenal and lung metastatic lesions developed 3 years after ablative I-131 therapy for cervical lymph node and skeletal metastases. Tc-99m MIBI planar and SPECT images demonstrated these new lesions better than pretherapy I-131 scintigraphy and affords an imaging technique for post-I-131 therapy follow-up that does not require withholding thyroid hormone suppression.

摘要

铊 - 201以及最近的锝 - 99m甲氧基异丁基异腈(MIBI)已与碘 - 131闪烁显像联合用于分化型甲状腺癌患者的随访。甲状腺岛状癌是一种侵袭性较强的甲状腺肿瘤,被认为起源于滤泡细胞,通常会摄取碘 - 131。作者报告了一名复发性甲状腺岛状癌患者,该患者在接受碘 - 131消融治疗颈部淋巴结和骨转移3年后出现双侧肾上腺和肺部转移灶。锝 - 99m MIBI平面显像和单光子发射计算机断层扫描(SPECT)图像比治疗前碘 - 131闪烁显像能更好地显示这些新病灶,并提供了一种碘 - 131治疗后随访的成像技术,该技术无需停用甲状腺激素抑制治疗。

相似文献

1
Tc-99m MIBI scintigraphic detection of metastatic insular thyroid carcinoma.锝-99m甲氧基异丁基异腈闪烁扫描术检测转移性甲状腺岛状癌
Clin Nucl Med. 1995 Jan;20(1):31-6. doi: 10.1097/00003072-199501000-00008.
2
Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma.
Eur J Nucl Med. 1995 Oct;22(10):1218-20. doi: 10.1007/BF00800609.
3
Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.18F-FDG 全身PET、99mTc-MIBI单光子发射计算机断层显像(SPET)及治疗后131I-Na闪烁扫描术在转移性甲状腺癌检测中的比较
Eur J Nucl Med Mol Imaging. 2004 Apr;31(4):491-8. doi: 10.1007/s00259-003-1403-y. Epub 2003 Dec 10.
4
Clinical importance of technetium-99m-methoxyisobutylisonitrile (MIBI) scintigraphy in differentiated thyroid carcinoma patients with elevated thyroglobulin levels and negative I-131 scanning results.锝-99m-甲氧基异丁基异腈(MIBI)闪烁扫描术在甲状腺球蛋白水平升高且碘-131扫描结果为阴性的分化型甲状腺癌患者中的临床意义。
Ann Nucl Med. 2006 Jul;20(6):393-7. doi: 10.1007/BF03027374.
5
Nuclear medicine approaches in the monitoring of thyroid cancer patients.核医学方法在甲状腺癌患者监测中的应用
J BUON. 2006 Oct-Dec;11(4):511-8.
6
Whole-body Tc-99m sestamibi scintigraphy in the follow-up of differentiated thyroid carcinoma.分化型甲状腺癌随访中的全身Tc-99m 甲氧基异丁基异腈闪烁扫描术
Clin Nucl Med. 2000 Jun;25(6):443-6. doi: 10.1097/00003072-200006000-00011.
7
Technetium-99m methoxyisobutylisonitrile imaging in the follow-up of differentiated thyroid carcinoma.锝-99m甲氧基异丁基异腈显像在分化型甲状腺癌随访中的应用
Ann Acad Med Singap. 2002 Mar;31(2):195-8.
8
Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid carcinoma.
J Nucl Med. 1997 Mar;38(3):352-6.
9
Diagnostic capabilities of I-131, TI-201, and Tc-99m-MIBI scintigraphy for metastatic differentiated thyroid carcinoma after total thyroidectomy.I-131、TI-201和Tc-99m-MIBI闪烁扫描术对全甲状腺切除术后转移性分化型甲状腺癌的诊断能力。
Acta Med Okayama. 2005 Jun;59(3):99-107. doi: 10.18926/AMO/31983.
10
Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.锝-99m亚甲基二膦酸盐与铊-201联合显像在检测甲状腺癌骨转移中的价值。
Thyroid. 1997 Oct;7(5):705-12. doi: 10.1089/thy.1997.7.705.

引用本文的文献

1
Use of Tc-sestamibi SPECT/CT when conventional imaging studies are negative for localizing suspected recurrence in differentiated thyroid cancer: a method and a lesson for clinical management.当常规影像学检查对分化型甲状腺癌可疑复发病灶的定位呈阴性时使用 Tc-sestamibi SPECT/CT:一种方法和临床管理的经验教训。
Endocrine. 2018 Oct;62(1):57-63. doi: 10.1007/s12020-018-1636-y. Epub 2018 May 24.
2
Insular carcinoma of thyroid: A case report.甲状腺岛叶癌:一例报告。
Indian J Otolaryngol Head Neck Surg. 2006 Jul;58(3):290-1. doi: 10.1007/BF03050846.